Featured Articles

31. New Era Of Increased DCTs Shows Promise For Site Success 2/17/2023

    DCTs are increasingly popular, but they’re often underutilized. What steps can sponsors take to ensure that their DCTs are successful? The answer: build positive relationships.

32. The Evolution And Proliferation Of Decentralized Clinical Trial Technologies 2/2/2023

    Clinical trials tend to lag behind the innovation adoption curve, but the pace of technology’s proliferation has helped to propel its application to DCTs.

33. Holistic Implementation Of DCT Elements Drives Modern Research 2/2/2023

    Unearth the benefits of a DCT approach, such as additional flexibility that expands patient choices and extends a human touch into patient homes by replicating services normally performed on-site.

34. Complex DCT Delivery: What Is Possible Outside Of A Site? 1/18/2023

    Todd McGrath, Chief Operating Officer, and Emily McDougal, Executive Director of Nurse Management, show how the decentralized delivery of complex clinical visits can benefit studies, sites, and patients.

35. How Level Of Touch Guides DCT Tools And Methods 10/24/2022

    To run clinical trials quickly, safely, and with high data integrity, it's effective to assess trials by degree of touch. Discover how different trial types are suited to the application of different tools and methods.

36. What Does “Good” Look Like In A Decentralized Clinical Trial? 8/23/2022

    Delve into the answer to the question: What is the right way to perform decentralized trials in order that it can be controlled and managed effectively?

37. The Catalyst Of Decentralized Clinical Trials: Combining Clinical And Digital 7/27/2022

    Decentralized clinical trials are made up of a multitude of elements, from in home clinical capabilities, logistics, digital platforms, and technology, to global reach and more. This webinar shares important factors to consider to build your DCT ‘molecule’ successfully.

38. Tau Pathology Clinical Trial 4/28/2022

    Working in close collaboration with the manufacturer of a novel treatment for Progressive Supranuclear Palsy, MRN played a major role in delivering Home Trial Support (HTS) for 79 patients in several different countries.

39. Early Onset Alzheimer's Trial 3/24/2022

    Washington University conducted several trials of a rare, inherited form of Alzheimer's that typically develops in a person's 50s, 40s or even 30s. Find out how they were able to be assisted in this case study.

40. How Continuous Improvement Ethos Serves Patients And Clients 3/10/2022

    Discover how years of experience bolstered by continuous improvement efforts, enable hybrid clinical trial execution, from in-home clinical visits to site networks and digital platforms and technology.